XML 20 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating Activities    
Net Income Including the Noncontrolling Interests in Subsidiaries $ 160,667 $ 162,927
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities    
Amortization of Deferred Sales Commissions 2,319 6,580
Depreciation and Other Amortization 10,767 7,788
Share-Based Compensation Expense 18,244 17,290
Gain on Disposal of Assets (7) (5,358)
Provision for Deferred Income Taxes 7,813 8,226
Fair-Value Adjustments for Contingent Liabilities 97 0
Net Unrealized Loss (Gain) on Investments 1,801 (1,019)
Net Sales of Investments—Consolidated Investment Companies 9,302 21,314
Deferred Sales Commissions Paid (43) (3,737)
Contingent Deferred Sales Charges Received 0 1,484
Other Changes in Assets and Liabilities:    
Increase in Receivables, net (9,462) (303)
(Increase) Decrease in Prepaid Expenses and Other Assets (1,009) 1,477
Decrease in Accounts Payable and Accrued Expenses (121,611) (23,360)
Increase in Other Liabilities 7,492 4,054
Net Cash Provided by Operating Activities 86,370 197,363
Investing Activities    
Purchases of Investments—Affiliates and Other (3,081) (4,730)
Cash Paid for Business Acquisitions, Net of Cash Acquired (168,430) (4,352)
Proceeds from Redemptions of Investments—Affiliates and Other 19,986 17,235
Cash Paid for Property and Equipment (11,900) (6,791)
Net Cash (Used) Provided by Investing Activities (163,425) 1,362
Financing Activities    
Dividends Paid (79,808) (76,286)
Purchases of Treasury Stock (27,064) (44,152)
Distributions to Noncontrolling Interest in Subsidiaries (9,778) (8,929)
Contributions from Noncontrolling Interest in Subsidiaries 4,425 4,095
Cash Paid for Amended and Restated Credit Agreement 0 (483)
Proceeds from Shareholders for Share-Based Compensation 222 90
Proceeds from New Borrowings 79,150 0
Payments on Contingent Consideration Liabilities (228) (210)
Payments on Debt (89,150) (16,250)
Net Cash Used by Financing Activities (122,231) (142,125)
Net (Decrease) Increase in Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (199,286) 56,600
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning of Period 316,809 105,355
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period 117,523 161,955
Less: Restricted Cash and Restricted Cash Equivalents Recorded in Other Long-Term Assets 580 545
Cash and Cash Equivalents $ 116,943 $ 161,410